SOFTBANK GROUP CORP.
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 13 quarters, returned +6.6% per quarter — versus +2.2% per quarter from simply owning every 13F stock. It beat that baseline in only 61.5% of quarters (excess t = 1.09, not statistically significant). Its filings tell you what it bought — not what you should buy.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 20 holdings of 29 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| INTC | $3.8B | | HOLD |
| SYM | $2.1B | | HOLD |
| TMUS | $2.1B | | TRIM |
| TSM | $671M | | HOLD |
| XXI | $570M | | HOLD |
| INTR | $482M | | HOLD |
| WBTN | $289M | | HOLD |
| NU | $256M | | HOLD |
| TEM | $244M | | HOLD |
| KLAR | $202M | | HOLD |
| VTEX | $154M | | HOLD |
| QXO | $106M | | HOLD |
| CHYM | $95M | | HOLD |
| RXRX | $42M | | HOLD |
| AFYA | $36M | | HOLD |
| LIFE | $35M | | NEW |
| YMM | $32M | | HOLD |
| PACB | $27M | | HOLD |
| ETOR | $24M | | HOLD |
| BETR | $22M | | HOLD |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
None.
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.